Vaxcyte (NASDAQ:PCVX – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at BTIG Research in a note issued to investors on Monday, Benzinga reports. They presently have a $89.00 price target on the stock. BTIG Research’s price objective suggests a potential upside of 22.39% from the company’s previous close. A number […]

Vaxcyte (NASDAQ:PCVX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at BTIG Research in a report issued on Monday, Marketbeat.com reports. They currently have a $89.00 price objective on the stock. BTIG Research’s price objective indicates a potential upside of 20.56% from the company’s previous close. PCVX has been the […]